photo of

Details

Role Group Leader/Clinician-Scientist Fellow

Contact

Available for student supervision
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.

Top Publications

  • Lawrence, J, Gwee, A, Quinlan, C. Pneumococcal haemolytic uraemic syndrome in the postvaccine era. Archives of Disease in Childhood 103(10) : 957 2018
    view publication
  • Wilkins, AL, Steer, AC, Cranswick, N, Gwee, A. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?. Archives of Disease in Childhood 103(5) : 514 2018
    view publication
  • Andrew, EC, Curtis, N, Coghlan, B, Cranswick, N, Gwee, A. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations. British Journal of Clinical Pharmacology 84(5) : 1006 -1012 2018
    view publication
  • van den Heuvel, N, O'Leary, C, Gwee, A. Meningococcal Meningitis Complicated by Ventriculitis in an Infant. Journal of Paediatrics and Child Health 54(2) : 213 -214 2018
    view publication
  • Boast, A, Gwee, A, Gwee, A. Teicoplanin—Should We Be Doing Routine Therapeutic Drug Monitoring in Children?. The Pediatric Infectious Disease Journal 36(11) : 1110 2017
    view publication

Page 13 of 20